Say 'n ho' to Novo Nordisks new Chinese-language chatbot for people with diabetes

More than one-fourth of the world’s diabetes patients live in Chinaࢀ"and Novo Nordisk wants to give them a better way to ask questions and get information. It’s partnering with Microsoft to create a Chinese-language AI chatbot, set to launch early next year on the Danish drugmaker’s digital patient support platforms. The artificially intelligent chatbot will help deliver relevant information in both voice and text to the countryࢀ™s massive diabetes population of 129 millionࢀ"many of whom face difficulties managing their condition. Fewer than 16% of people control their disease well because of late diagnosis, poor medical attention or just not understanding…